SEC Form 4 · accession 0001493152-18-003720
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Allen Wolff
Officer — CFO and EVP
Period of report
Mar 19, 2018
Accepted (ET)
Mar 21, 2018 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 19, 2018 | A | 15,000 | $0.00 | A | 50,716 | D | |
| Common StockF2 | holding | — | — | — | 2,100 | I | See note | |
| Common StockF3 | holding | — | — | — | 2,100 | I | See note |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares subject to a restricted stock unit award granted under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan. The award will vest as to 16.67% of the shares subject to the award on the 6-month anniversary of the grant date and the remaining 83.33% of the shares will vest in 30 substantially equal monthly installments beginning on the 7-month anniversary of the grant date, in each case, subject to the reporting person's continued service to the issuer as of the applicable vesting date.
- F2As custodian of Minor Child 1.
- F3As custodian of Minor Child 2.